Multiply Labs
Scott Dylla is the current advisor at Multiply Labs. Scott has also been a part of Chimera Bioengineering, AbbVie Stemcentrx, LLC, and Stemcentrx, Inc. Scott was the co-founder and Chief Scientific Officer at Stemcentrx, Inc. and has also worked as a Sr. Scientist at OncoMed Pharmaceuticals and a Postdoctoral Scholar at Stanford University School of Medicine.
Scott Dylla has a Ph.D. in Cancer Biology & Immunology from the University of Minnesota, an M.S. in Molecular & Cellular Pathobiology from the University of Alabama at Birmingham, and a B.S. in Biochemistry & Molecular Biology from the University of Minnesota Duluth.
This person is not in the org chart
This person is not in any offices
Multiply Labs
2 followers
Multiply Labs develops robotic systems that manufacture small-batch drugs. Current pharma production methods are manual, slow, and costly. We believe that the only way to scale them is with cloud-controlled robots.